Argininemia: A treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: Case reports and literature review

Journal of Child Neurology

Volumn 12, Issue 5, 1997, Pages 301-309

  Prasad, Asuri N ^a   Breen, Joan C ^a   Ampola, Mary G ^a   Rosman, N Paul ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMMONIA; ARGINASE; ARGININE; BENZOIC ACID; CARBOXYLIC ACID; CONTRAST MEDIUM; GLUTAMINE; HOMOCITRULLINE; INSULIN; LACTULOSE; PHENOBARBITAL; PHENYLACETIC ACID DERIVATIVE; PROTEIN; UREA;

AMINO ACID BLOOD LEVEL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CEREBRAL PALSY; CLINICAL ARTICLE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; DIET THERAPY; DISEASE SEVERITY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DRUG MIXTURE; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPERAMMONEMIA; MALE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SEIZURE;

EID: 0030883916     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389701200502     Document Type: Article

References (44)

1. Batshaw ML: Inborn errors of urea synthesis. Ann Neurol 1994; 35:133-141.
2. Brusilow SW, Horwich AL: Urea cycle enzymes, in Scriver C, Beaudet A, Sly W, Valle D (eds): The Metabolic and Molecular Basis of Inherited Disease, 7th ed. New York, McGraw-Hill, 1995 pp 1187-1232.
3. Terheggen HG, Schwenk A, Lowenthal A, et al: Argininemia with arginase deficiency. Lancet 1969;2:748-749.
4. Terheggen HG, Lavinha F, Colombo JP, et al: Familial hyperargininemia. J Genet Hum 1972;20:69-84.
5. Terheggen HG, Lowenthal A, Lavinha F, et al: Familial hyperargininemia. Arch Dis Child 1975;50:57-62.
6. Snyderman SE, Sansaricq C, Chen WJ, et al: Argininemia. J Pediatr 1977;90:563-568.
7. Cederbaum SD, Shaw KNF, Valente M: Hyperargininemia. J Pediatr 1977;90:569-573.
8. Michels W, Beaudet AL: Arginase deficiency in multiple tissues in argininemia. Clin Genet 1978;13:61-67.
9. Cederbaum SD, Shaw KNF, Spector EB, et al: Hyperargininemia with arginase deficiency. Pediatr Res 1979;13:827-833.
10. Snyderman SE, Sansaricq C, Norton PM, et al: Argininemia treated from birth. J Pediatr 1979;95:61-63.
11. Qureshi IA, Letarte J, Quellet R, et al: Ammonia metabolism in a family affected by hyperargininemia. Diabete Metab 1981;7:5-11.
12. Yoshino M, Kubota K, Ichiro Y, et al: Argininemia: Report of a new case and mechanisms of orotic aciduria and hyperammonemia, in Lowenthal A, Mori A, Marescau B (eds): Urea Cycle Diseases. New York, Plenum Press, 1983, pp 121-125.
13. Cederbaum SD, Moedjono SJ, Shaw KNF, et al: Treatment of hyperargininemia due to arginase deficiency with a chemically defined diet. J Inherited Metab Dis 1982;5:95-99.
14. Sakiyama T, Nakabayashi H, Kondo Y, et al: Argininemia: Clinical course and trial of enzyme replacement therapy. Biomed Therapeut 1982;8:907-910.
15. Qureshi IA, Letarte J, Ouellet R, et al: A new French Canadian family affected by hyperargininemia. J Inherited Metab Dis 1983;6: 179-182.
16. Mizutani N, Maehara M, Hayakawa C, et al: Hyperargininemia: Clinical course and treatment with sodium benzoate and phenylacetic acid. Brain Dev 1983;5:553-563.
17. Kang SS, Wong PWK, Melyn MA: Hyperargininemia: Effect of ornithine and lysine supplementation. J Pediatr 1983;103:763-765.
18. Qureshi IA, Letarte J, Ouellet R, et al: Treatment of hyperargininemia with sodium benzoate and arginine restricted diet. J Pediatr 1984;104:473-476.
19. Endres W, Schaller R, Shin YS: Diagnosis and treatment of argininemia: Characteristics of arginase in human erythrocytes and tissues. J Inherited Metab Dis 1984;7:8.
20. Jorda A, Rubio V, Portoles M, et al: A new case of arginase deficiency in a Spanish male. J Inherited Metab Dis 1986;9:393-397.
21. Bernar J, Hanson RA, Kern BP, et al: Arginase deficiency in a twelve year old boy with mild impairment of intellectual function. J Pediatr 1986;108:432-435.
22. Antonozzi I, Leuzzi V: Hyperargininemia. J Inherited Metab Dis 1987;10:200.
23. Romano C, Pescetto T, Cerone R, et al: Clinical and biochemical studies on a new patient affected by argininemia. Perspect Inherited Metab Dis 1987;7:19-22.
24. Brockstedt M, Smit LME, De Grauw AJC, et al: A new case of hyperargininemia: Neurological and biochemical findings prior to and during dietary treatment. Eur J Pediatr 1990;149:341-343.
25. Lambert MA, Marescau B, Desjardins M, et al: Hyperargininemia: Intellectual and motor improvement related to changes in biochemical data. J Pediatr 1991;118:420-424.
26. Schuerle AE, McVie R, Beaudet AL, et al: Arginase deficiency presenting as cerebral palsy. Pediatrics 1993;91:995-997.
27. Sparkes RS, Dizekes GJ, Klisak I, et al: The gene for human liver arginase is assigned to chromosome band 6q 23. Am J Hum Genet 1986;39:186-193.
28. Grody WW, Klein D, Dodson AE, et al: Molecular genetic study of human arginase deficiency. Am J Hum Genet 1992;50:1281-1290.
29. Grody WW, Kern RM, Klein D, et al: Arginase deficiency manifesting as delayed clinical sequelae and induction of a kidney arginase isozyme. Hum Genet 1993;91:1-5.
30. Marescau B, Qureshi IA, de Deyn PP, et al: Guanidino compounds in plasma, urine, and cerebrospinal fluid of hyperargininemic patients during therapy. Clin Chim Acta 1985;146:21-27.
31. Marescau B, de Deyn PP, Lowenthal A, et al: Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: Follow up of guanidino compounds during therapy. Pediatr Res 1990;27:297-303.
32. Mori A: Biochemistry and neurotoxicology of guanidino compounds; History and recent advances. Pavlov J Biol Sci 1983; 22:85-94.
33. Dawson TM, Dawson VL, Snyder SH: A novel neuronal messenger molecule in the brain: The free radical, nitric oxide. Ann Neurol 1992;32:297-311.
34. Peunova N, Enikolopov G: Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 1995; 375:68-73.
35. Freeman JM, Nelson KB: Intrapartum asphyxia and cerebral palsy. Pediatrics 1988;82:240-249.
36. Volpe JJ: Hypoxic ischemic encephalopathy: Clinical aspects, in Neurology of the Newborn, 3rd ed. Philadelphia, WB Saunders, 1995, pp 314-369.
37. Bharucha NE, Bharucha EP: Regional neurology, in Bradley WG, Daroff RB, Fenichel GM, et al (eds): Neurology in Clinical Practice, vol 2, 1st ed. Boston, Butterworth Heinemann, 1991, pp 1927-1928.
38. Osame M, Usuku K, Izumo S, et al: HTLV-1 associated myelopathy, a new clinical entity. Lancet 1986;1:1031-1032.
39. m variant causing late onset bilateral optic neuropathy. Arch Dis Child 1992;67:115-120.
40. Harding AE: Hereditary "pure" spastic paraplegia: A clinical and genetic study of 22 families. J Neurol Neurosurg Psychiatry 1981;44:871-883.
41. Brusilow SW, Danney M, Waber LJ, et al: Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med 1984;310:1630-1634.
42. Rogers S, Lowenthal A, Terheggen HG, et al: Induction of arginase activity with the Shope papilloma virus in tissue culture cells from an argininemic patient. J Exp Med 1973;137:1091-1096.
43. Wang WW, Jenkinson CP, Griscavage JM, Kern RM, et al: Coinduction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 1995;210:1009-1016.
44. Dawson VL, Dawson TM, Bartley DA, et al: Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993;13:2651-2661.